Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Potential of 18F-FDG-PET and PET/CT in nonmalignant pulmonary disorders: much more than currently perceived? Making the case from experience gained in the Indian scenario.

Basu S, Yadav M, Joshi J.

Nucl Med Commun. 2014 Jul;35(7):689-96. doi: 10.1097/MNM.0000000000000127. No abstract available.

PMID:
24736327
2.

The pivotal role of FDG-PET/CT in modern medicine.

Hess S, Blomberg BA, Zhu HJ, Høilund-Carlsen PF, Alavi A.

Acad Radiol. 2014 Feb;21(2):232-49. doi: 10.1016/j.acra.2013.11.002. Review.

PMID:
24439337
3.

Pulmonary amyloidosis in a patient with Langerhans cell histiocytosis: diagnostic dilemma on 18F-FDG PET/CT.

Mukherjee A, Dhull VS, Sharma P, Parida GK, Jain S, Pal L, Kumar R.

Clin Nucl Med. 2014 Apr;39(4):e263-4. doi: 10.1097/RLU.0b013e3182a7556d.

PMID:
24097004
4.

Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging.

Wachsmann JW, Gerbaudo VH.

PET Clin. 2014 Apr;9(2):147-68. doi: 10.1016/j.cpet.2013.10.004. Epub 2013 Dec 12. Review.

PMID:
25030279
5.

[Detection of pulmonary tumor thrombosis by integrated 18F-FDG PET/CT scans with intravenous contrast].

Valls E, Garcia JR, Rodriguez R, Soler M, Moragas M, Lomeña F.

Rev Esp Med Nucl Imagen Mol. 2013 Jan;32(1):49-51. doi: 10.1016/j.remn.2012.01.003. Epub 2012 Mar 14. Spanish. No abstract available.

6.

Can multimodality imaging using 18F-FDG/18F-FLT PET/CT benefit the diagnosis and management of patients with pulmonary lesions?

Xu B, Guan Z, Liu C, Wang R, Yin D, Zhang J, Chen Y, Yao S, Shao M, Wang H, Tian J.

Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):285-92. doi: 10.1007/s00259-010-1625-8. Epub 2010 Oct 9.

PMID:
20936411
7.

Pulmonary brucellosis on FDG PET/CT.

Zhang T, Wang C, Niu R, Wang X.

Clin Nucl Med. 2014 Feb;39(2):222-3. doi: 10.1097/RLU.0000000000000327.

PMID:
24368538
8.

The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.

Qiu L, Chen Y, Wu J.

Hell J Nucl Med. 2013 Sep-Dec;16(3):230-6. doi: 10.1967/s0024499100091. Epub 2013 Oct 2. Review.

PMID:
24137577
9.

Imaging spectrum and pitfalls of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with tuberculosis.

Ito K, Morooka M, Minamimoto R, Miyata Y, Okasaki M, Kubota K.

Jpn J Radiol. 2013 Aug;31(8):511-20. doi: 10.1007/s11604-013-0218-4. Epub 2013 May 30. Review.

PMID:
23719763
10.

Human Cerenkov imaging using 18F-FDG.

Spinelli AE, Boschi F.

J Nucl Med. 2014 Mar;55(3):523. doi: 10.2967/jnumed.113.135384. Epub 2014 Jan 21. No abstract available.

11.

Reply: Human Cerenkov imaging using 18F-FDG.

Thorek DL, Riedl CC, Grimm J.

J Nucl Med. 2014 Mar;55(3):523-4. doi: 10.2967/jnumed.113.135533. Epub 2014 Jan 21. No abstract available.

12.

Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.

Fleisher KE, Raad RA, Rakheja R, Gupta V, Chan KC, Friedman KP, Mourtzikos KA, Janal M, Glickman RS.

J Oral Maxillofac Surg. 2014 Oct;72(10):1957-65. doi: 10.1016/j.joms.2014.04.017. Epub 2014 Apr 24.

PMID:
25053572
13.

Case of pulmonary cryptococcosis mimicking hematogeneous metastases in an immunocompetent patient: value of absent 18F-fluorodeoxyglucose uptake on positron emission tomography/CT scan.

Lee CH, Tzao C, Chang TH, Chang WC, Huang GS, Lin CK, Lin HC, Hsu HH.

Korean J Radiol. 2013 May-Jun;14(3):540-3. doi: 10.3348/kjr.2013.14.3.540. Epub 2013 May 2.

14.

Extensive peritoneal and pleural lymphomatosis in a patient with Burkitt lymphoma revealed with 18F-FDG PET/CT.

Uslu L, Sen F, Sager S, Halaç M.

Nuklearmedizin. 2013;52(5):N56-7. No abstract available.

PMID:
24085460
15.

The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.

Treglia G, Annunziata S, Sobic-Saranovic D, Bertagna F, Caldarella C, Giovanella L.

Acad Radiol. 2014 May;21(5):675-84. doi: 10.1016/j.acra.2014.01.008. Review.

PMID:
24703482
16.

18F-FDG PET/CT findings in patients with Kikuchi disease.

Kong E, Chun K, Hong Y, Hah J, Cho I.

Nuklearmedizin. 2013;52(3):101-6. doi: 10.3413/Nukmed-0513-12-06. Epub 2013 Mar 27.

PMID:
23681151
17.

Potential role of FDG PET/CT in evaluating patients with hepatic incidentalomas.

Grassetto G, Marzola MC, Chondrogiannis S, Maffione AM, Rampin L, Galeotti F, Colletti PM, Rubello D.

Clin Nucl Med. 2014 Feb;39(2):156-9. doi: 10.1097/RLU.0000000000000312. Review.

PMID:
24321829
18.

Findings of pulmonary amyloidosis on dual phase FDG PET/CT imaging.

Tan H, Guan Y, Zhao J, Lin X.

Clin Nucl Med. 2010 Mar;35(3):206-7. doi: 10.1097/RLU.0b013e3181cc64b5. No abstract available.

PMID:
20173462
19.

Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.

Treglia G, Sadeghi R, Annunziata S, Lococo F, Cafarotti S, Bertagna F, Prior JO, Ceriani L, Giovanella L.

Acad Radiol. 2014 Jan;21(1):11-20. doi: 10.1016/j.acra.2013.09.015. Review.

PMID:
24331260
20.

Is 18F-FDG-PET/CT really able to differentiate between malignant and benign solitary fibrous tumor of the pleura?

Lococo F, Cafarotti S, Treglia G.

Clin Imaging. 2013 Sep-Oct;37(5):976. doi: 10.1016/j.clinimag.2013.03.003. Epub 2013 Jul 6. No abstract available.

PMID:
23834904
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk